European Case Law Identifier: | ECLI:EP:BA:2006:T102302.20060519 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 19 May 2006 | ||||||||
Case number: | T 1023/02 | ||||||||
Application number: | 91918320.2 | ||||||||
IPC class: | A61K 39/12 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Recombinant herpes simplex viruses vaccines and methods | ||||||||
Applicant name: | Arch Development Corporation | ||||||||
Opponent name: | University College London The University Court of the University of Glasgow |
||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Added matter (no) - novelty, inventive step, sufficiency of disclosure (yes) | ||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t021023eu1.html
Date retrieved: 17 May 2021
8 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: II Conditions to be met by an Application
XCLR II A 6.2 Meaning of terms and phrases: "comprising (substantially)", "consisting (essentially) of", "containing"